XSHE
002915
Market cap816mUSD
Oct 09, Last price
16.66CNY
1D
2.21%
1Q
-9.51%
IPO
243.51%
Name
Zhejiang Zhongxin Fluoride Materials Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Zhejiang Zhongxin Fluoride Materials Co., Ltd (002915.SZ) is a Chinese enterprise dedicated to the research, production, and distribution of advanced fluorine fine chemicals. Its extensive product portfolio encompasses a variety of fluorine-containing compounds, such as cyanobenzene, benzoic acid, phenol, phenylcarbinol, phenylamine, and nitrobenzene. The company also supplies arene series, acetophenone, and heterocyclic ring derivatives, among others. These specialized chemical intermediates are crucial for diverse industrial applications, including pharmaceuticals, agrochemicals, novel materials development, and electronic chemicals. While primarily operating within China, the company also maintains an international sales presence, exporting its goods to key markets like Germany, Japan, and India. Established in Shaoxing, China, in the year 2000, Zhejiang Zhongxin Fluoride Materials Co., Ltd has built a strong foundation in the chemical industry.
Key people
Jianguo Xu
Chairman of the Board, General Manager · since 2022
Yu Chen
Deputy General Manager · since 2024
Zhengjun Shi
Deputy General Manager · since 2015
Weiliang Yu
Deputy General Manager · since 2025
Qiliang Yuan
Deputy General Manager · since 2013
Guolu Cao
Director · since 2007
Yingao Chen
Director · since 2022
Liufang Liang
Director
Chao Wang
Director · since 2022
Qinwei Xu
Staff Elected Director · since 2025
Yinzi Xu
Director · since 2022
Junwen Yan
Director · since 2022
Shaolan Yuan
Chief Financial Officer, Secretary of the Board, Director · since 2015
Quan Li
Independent Director · since 2025
Xuanming Ni
Independent Director · since 2022
Xuanming Ni
Independent Director · since 2022
Weike Su
Independent Director · since 2022
Zhongzhi Yang
Independent Director
Jinsong Yu
Independent Director · since 2016
Kang Yuan
Independent Director · since 2022
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||